Donepezil and Memantine Tablets
PSYMENTA- PLUS
Product description:– Paymenta – Plus combines Donepezil, an acetylcholinesterase inhibitor, and Memantine, an NMDA receptor antagonist, for a comprehensive approach in managing moderate to severe Alzheimer’s disease.
Mechanism of Action:- Donepezil inhibits acetylcholinesterase, boosting brain acetylcholine levels to enhance cognition and memory. Memantine blocks NMDA receptors, reducing glutamate-induced excitotoxicity to protect neurons and support cognitive function. Combined, they offer symptomatic relief and cognitive stabilization for Alzheimer’s patients.
Indication:- Moderate to severe Alzheimer’s disease,memory, Cognition, and behavioral symptoms, Support daily functioning and quality of life,Combines dual action on cholinergic and glutamatergic systems.
 Common side effects:-
- Headache, dizziness
- Nausea, diarrhea
- Fatigue, confusion
Storage:-Store in a cool, dry place below 28°C. Protect from direct light and moisture,Keep out of reach of children.
